Trial reportPloS one2021
Smokers' cognitive and behavioural reactions during the early phase of the COVID-19 pandemic: Findings from the 2020 ITC Four Country Smoking and Vaping Survey.
Trial report in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Impact of the COVID-19 Pandemic on Smoking Consumption: A Systematic Review of Longitudinal Studies.Frontiers in psychiatry · 2022Pooled it
- Association Between SARS-CoV-2-Related Experiences and Smoking Cessation in Switzerland: A Repeated Cross-Sectional Study.International journal of environmental research and public health · 2026Article
- Global Trends and Emerging Frontiers in Smoking and Smokeless Tobacco Research: A Bibliometric Analysis over the Past Decade.Healthcare (Basel, Switzerland) · 2025Review
- An examination of the relationship between perceptions that cigarette smoking increases the severity of COVID-19 and reduction in smoking during the COVID-19 pandemic: Findings from the 2021 ITC Korea Survey.Tobacco induced diseases · 2025Article
- Change in prevalence of smoking during the first year of the COVID-19 pandemic among middle-aged and older adults in Canada: a cohort study of the Canadian Longitudinal Study on Aging.BMJ public health · 2024Article
- Sales of tobacco and nicotine replacement therapy products, especially nicotine pouches, increased in Finland during the COVID-19 pandemic.Nordisk alkohol- & narkotikatidskrift : NAT · 2024Article
- The association of psychological distress and economic and health worries with tobacco smoking behavior during the COVID-19 pandemic: a two-year longitudinal cohort study.BMC public health · 2024Article
- Use of tobacco during COVID-19: A qualitative study among medically underserved individuals.PloS one · 2024Article
- Influence of the home smoking environment and stress on smoking behaviors during the COVID-19 pandemic among patients of federally qualified health centers in rural Georgia.Tobacco prevention & cessation · 2024Article
- Our perception may not be reality: A longitudinal study of the relationship between perceived and actual change in smoking behavior.PloS one · 2024Article
- Association between sociodemographics and change in alcohol or tobacco use behaviors during the COVID-19 pandemic.PloS one · 2024Article
- A qualitative study on tobacco use during the COVID-19 pandemic in Lebanon: Waterpipe and cigarette smokers' views, risk perceptions, and behaviors.Tobacco prevention & cessation · 2024Article
- Article
- Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model.Canadian journal of public health = Revue canadienne de sante publique · 2023Article
- Smoking as a Risk or Protective Factor in Developing and Severity of COVID-19?Journal of acute medicine · 2023Article
- Differences in demographics and behaviors across two web-based survey platforms: Observations from a study of risk perceptions of heated tobacco products (HTPs).Preventive medicine reports · 2023Article
- Examining Disparities in Current E-Cigarette Use among U.S. Adults before and after the WHO Declaration of the COVID-19 Pandemic in March 2020.International journal of environmental research and public health · 2023Article
- The association between risk perceptions, anxiety, and self-reported changes in tobacco and nicotine product use due to COVID-19 in May-June 2020 in Israel.BMC public health · 2023Article
- Cutting down, quitting and motivation to stop smoking by self-reported COVID-19 status: Representative cross-sectional surveys in England.Addiction (Abingdon, England) · 2023Article
- Associations between Tobacco Use, Surges, and Vaccination Status over Time in the COVID-19 Era.International journal of environmental research and public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
introductionCOVID-19 is primarily a respiratory illness, and smoking adversely impacts the respiratory and immune systems; this confluence may therefore incentivize smokers to quit. The present study, conducted in four high-income countries during the first global wave of COVID-19, examined the association between COVID-19 and: (1) thoughts about quitting smoking; (2) changes in smoking (quit attempt, reduced or increased smoking, or no change); and (3) factors related to a positive change (making a quit attempt or reducing smoking) based on an adapted framework of the Health Belief Model.
methodsThis cross-sectional study included 6870 adult smokers participating in the Wave 3 (2020) ITC Four Country Smoking and Vaping Survey conducted in Australia, Canada, England, and United States (US). These four countries had varying responses to the pandemic by governments and public health, ranging from advising voluntary social distancing to implementing national and subnational staged lockdowns. Considering these varying responses, and the differences in the number of confirmed cases and deaths (greatest in England and the US and lowest in Australia), smoking behaviours related to COVID-19 may have differed between countries. Other factors that may be related to changes in smoking because of COVID-19 were also explored (e.g., sociodemographics, nicotine dependence, perceptions about personal and general risks of smoking on COVID-19). Regression analyses were conducted on weighted data.
resultsOverall, 46.7% of smokers reported thinking about quitting because of COVID-19, which differed by country (p<0.001): England highest (50.9%) and Australia lowest (37.6%). Thinking about quitting smoking because of COVID-19 was more frequent among: females, ethnic minorities, those with financial stress, current vapers, less dependent smokers (non-daily and fewer cigarettes smoked/day), those with greater concern about personal susceptibility of infection, and those who believe COVID-19 is more severe for smokers. Smoking behaviour changes due to COVID-19 were: 1.1% attempted to quit, 14.2% reduced smoking, and 14.6% increased smoking (70.2% reported no change). Positive behaviour change (tried to quit/reduced smoking) was reported by 15.5% of smokers, which differed by country (p = 0.02), where Australia had significantly lower rates than the other three countries. A positive behavioural smoking change was more likely among smokers with: lower dependence, greater concern about personal susceptibility to infection, and believing that COVID-19 is more severe for smokers.
conclusionsThough nearly half of smokers reported thinking about quitting because of COVID-19, the vast majority did not change their smoking behaviour. Smokers were more likely to try and quit or reduce their smoking if they had greater concern about susceptibility and severity of COVID-19 related to smoking. Smokers in Australia were least likely to reduce or try to quit smoking, which could be related to the significantly lower impact of COVID-19 during the early phase of the pandemic relative to the other countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.